Theo dõi
Brian Alexander
Brian Alexander
Associate Professor of Radiation Oncology, Harvard Medical School, Dana-Farber Cancer Institute
Email được xác minh tại dfci.harvard.edu
Tiêu đề
Trích dẫn bởi
Trích dẫn bởi
Năm
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
PY Wen, M Weller, EQ Lee, BM Alexander, JS Barnholtz-Sloan, ...
Neuro-oncology 22 (8), 1073-1113, 2020
9622020
Adult glioblastoma
BM Alexander, TF Cloughesy
Journal of Clinical Oncology 35 (21), 2402-2409, 2017
8642017
Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study
DN Cagney, AM Martin, PJ Catalano, AJ Redig, NU Lin, EQ Lee, PY Wen, ...
Neuro-oncology 19 (11), 1511-1521, 2017
7522017
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials
BM Ellingson, M Bendszus, J Boxerman, D Barboriak, BJ Erickson, ...
Neuro-oncology 17 (9), 1188-1198, 2015
7322015
Pathologic complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: a comprehensive meta-analysis
LM Spring, G Fell, A Arfe, C Sharma, R Greenup, KL Reynolds, BL Smith, ...
Clinical cancer research 26 (12), 2838-2848, 2020
7052020
Estimating survival in patients with lung cancer and brain metastases: an update of the graded prognostic assessment for lung cancer using molecular markers (Lung-molGPA)
PW Sperduto, TJ Yang, K Beal, H Pan, PD Brown, A Bangdiwala, ...
JAMA oncology 3 (6), 827-831, 2017
6722017
Mechanisms and therapeutic implications of hypermutation in gliomas
M Touat, YY Li, AN Boynton, LF Spurr, JB Iorgulescu, CL Bohrson, ...
Nature 580 (7804), 517-523, 2020
5612020
Autophagy is critical for pancreatic tumor growth and progression in tumors with p53 alterations
A Yang, NV Rajeshkumar, X Wang, S Yabuuchi, BM Alexander, GC Chu, ...
Cancer discovery 4 (8), 905-913, 2014
5002014
Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin
R Woodhouse, M Li, J Hughes, D Delfosse, J Skoletsky, P Ma, W Meng, ...
PloS one 15 (9), e0237802, 2020
3442020
Immunotherapy and symptomatic radiation necrosis in patients with brain metastases treated with stereotactic radiation
AM Martin, DN Cagney, PJ Catalano, BM Alexander, AJ Redig, ...
JAMA oncology 4 (8), 1123-1124, 2018
3072018
Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma
M Abedalthagafi, WL Bi, AA Aizer, PH Merrill, R Brewster, PK Agarwalla, ...
Neuro-oncology 18 (5), 649-655, 2016
2992016
Brain metastases in newly diagnosed breast cancer: a population-based study
AM Martin, DN Cagney, PJ Catalano, LE Warren, JR Bellon, RS Punglia, ...
JAMA oncology 3 (8), 1069-1077, 2017
2982017
Adaptive platform trials: definition, design, conduct and reporting considerations
Nature Reviews Drug Discovery 18 (10), 797-807, 2019
2932019
Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas
B Zhang, K Chang, S Ramkissoon, S Tanguturi, WL Bi, DA Reardon, ...
Neuro-oncology 19 (1), 109-117, 2017
2702017
Updates in the management of brain metastases
ND Arvold, EQ Lee, MP Mehta, K Margolin, BM Alexander, NU Lin, ...
Neuro-oncology 18 (8), 1043-1065, 2016
2642016
A systematic evaluation of abscopal responses following radiotherapy in patients with metastatic melanoma treated with ipilimumab
RA Chandra, TJ Wilhite, TA Balboni, BM Alexander, A Spektor, PA Ott, ...
Oncoimmunology 4 (11), e1046028, 2015
2472015
Future cancer research priorities in the USA: a Lancet Oncology Commission
EM Jaffee, C Van Dang, DB Agus, BM Alexander, KC Anderson, ...
The Lancet Oncology 18 (11), e653-e706, 2017
2102017
Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial
H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ...
Jama 326 (17), 1690-1702, 2021
2072021
Somatic HLA class I loss is a widespread mechanism of immune evasion which refines the use of tumor mutational burden as a biomarker of checkpoint inhibitor response
M Montesion, K Murugesan, DX Jin, R Sharaf, N Sanchez, A Guria, ...
Cancer Discovery 11 (2), 282-292, 2021
2062021
Adaptive global innovative learning environment for glioblastoma: GBM AGILE
BM Alexander, S Ba, MS Berger, DA Berry, WK Cavenee, SM Chang, ...
Clinical Cancer Research 24 (4), 737-743, 2018
2052018
Hệ thống không thể thực hiện thao tác ngay bây giờ. Hãy thử lại sau.
Bài viết 1–20